Lower Transplacental Antibody Transport for Measles, Mumps, Rubella and Varicella Zoster in Very Preterm Infants
Open accessThe DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Maternal antibodies, transported over the placenta during pregnancy, contribute to the protection of infants from infectious diseases during the first months of life. In term infants, this protection does not last until the first recommended measles-mumps-rubella vaccination at 14 months in the Netherlands, while these viruses still circulate. The aim of the study was to investigate the antibody concentration against measles, mumps, rubella and varicella (MMRV) in mothers and preterm infants or healthy term infants at birth. METHODS: Antibody concentrations specific for MMRV were measured in cord blood samples from preterm (gestational age <32 weeks and/or birth weight <1500 g) and term infants, and matched maternal serum samples, using a fluorescent bead-based multiplex immune-assay. RESULTS: Due to lower placental transfer ratios of antibodies against MMRV in 96 preterm infants (range 0.75-0.87) compared to 42 term infants (range 1.39-1.65), the preterm infants showed 1.7-2.5 times lower geometric mean concentrations at birth compared to term infants. Maternal antibody concentration is the most important determinant of infant antibody concentration against MMRV. CONCLUSIONS: Preterm infants benefit to a lesser extent from maternal antibodies against measles, mumps, rubella and varicella than term infants, posing them even earlier at risk for infectious diseases caused by these still circulating viruses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Unfortunately, preterm babies, especially those born < 34 weeks, have reduced levels of protective antibodies.”
From Transplacental transfer of total immunoglobulin G and antibodies to Plasmodium falciparum antigens between the 24th week of gestation and term (2022) · cites this paper as [8]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Antibody concentration has an impact on transplacental transfer8,25–27.”
From Transplacental transfer of total immunoglobulin G and antibodies to Plasmodium falciparum antigens between the 24th week of gestation and term (2022) · cites this paper as [8]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“It follows therefore that a reduced transfer of IgG in preterm infants compared with term infants has been demonstrated for a variety of pathogens (97, 127, 128) particularly for infants born at less than 36 weeks of gestation (126).”
From Factors Affecting the FcRn-Mediated Transplacental Transfer of Antibodies and Implications for Vaccination in Pregnancy (2017) · cites this paper as [128]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Authority, E. F. S., & European Centre for Disease Prevention and Control (2015) · EFSA Journal · doi:10.2903/j.efsa.2015.3991 · Cited by 3,550
Morbidity and Mortality Weekly Report
(2011) · Wilderness & Environmental Medicine · doi:10.1016/j.wem.2010.11.007 · Cited by 3,423
Placental transport of immunoglobulin G
Simister, N. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00334-7 · Cited by 783
Measles Antibody: Reevaluation of Protective Titers
Chen, R. T., Markowitz, L. E., Albrecht, P., Stewart, J. A., Mofenson, L. M., Preblud, S. R., & Orenstein, W. A. (1990) · Journal of Infectious Diseases · doi:10.1093/infdis/162.5.1036 · Cited by 608 · cited 6×
“Protective concentrations for antimumps and anti-varicella antibodies are not internationally assigned, but locally assigned cut-off values of $45 RU/ml and $0.26 IU/ml, respectively, were used as previously described.”
InfluentialMcLean, H. Q., Fiebelkorn, A. P., Temte, J. L., & Wallace, G. S. (2013) · PubMed · Cited by 607
Evolution of Maternofetal Transport of Immunoglobulins During Human Pregnancy
Malek, A., Sager, R., Kuhn, P., Nicolaides, K. H., & Schneider, H. (1996) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.1996.tb00172.x · Cited by 559 · cited 2×
“[7,8] While the fetal IgG is approximately 10% of the maternal concentration at 17–22 weeks of gestation, it increases to 50% at 28–32 weeks of gestation as determined by chordocentesis.[1,9] The increase of fetal IgG concentrations between 29 and 41 weeks of gestation is twice that at 17 to 28 weeks of gestation.”
BackgroundSiegrist, C. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00342-6 · Cited by 346 · cited 1×
“However T cell priming is not prevented by maternal antibodies.[45] Inhibition by maternal antibodies cannot be the only reason for low seroconversion, as both preterm and term infants lose their antibodies well before vaccination, even if the vaccination is given at 6–9 months instead of 12–14 months.”
BackgroundMeasles in Europe: an epidemiological assessment
Muscat, M., Bang, H., Wohlfahrt, J., Glismann, S., & Mølbak, K. (2009) · The Lancet · doi:10.1016/s0140-6736(08)61849-8 · Cited by 219 · cited 5×
“[19,27] In the past 10 years, there were still outbreaks of measles with measles-related deaths all over Europe.”
BackgroundInfluentialTransplacental transport of IgG antibodies to preterm infants: A review of the literature
van den Berg, J. P., Westerbeek, E. A. M., van der Klis, F. R. M., Berbers, G. A. M., & van Elburg, R. M. (2011) · Early Human Development · doi:10.1016/j.earlhumdev.2010.11.003 · Cited by 212
Self-citationThe comparative sero-epidemiology of varicella zoster virus in 11 countries in the European region
Nardone, A., de Ory, F., Carton, M., Cohen, D., van Damme, P., Davidkin, I., Rota, M. C., de Melker, H., Mossong, J., Slacikova, M., et al. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.07.036 · Cited by 195 · cited 1×
“Varicella vaccination is not recommended in the Netherlands, but it is in other countries.[36] Varicella infection occurs at a younger age in the Netherlands compared to other countries.”
BackgroundSelf-citationRubella Immunity:Defining the Level of Protective Antibody
Skendzel, L. P. (1996) · American Journal of Clinical Pathology · doi:10.1093/ajcp/106.2.170 · Cited by 179
Waaijenborg, S., Hahne, S. J. M., Mollema, L., Smits, G. P., Berbers, G. A. M., van der Klis, F. R. M., de Melker, H. E., & Wallinga, J. (2013) · Journal of Infectious Diseases · doi:10.1093/infdis/jit143 · Cited by 178 · cited 9×
“Previously, Waaijenborg et al [18] showed that in general the Dutch population lose protective concentrations of maternal antibodies for measles at approximately 3.”
BackgroundMethodInfluentialSelf-citationStrebel, P. M., Papania, M. J., Dayan, G. H., & Halsey, N. A. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-3611-1.50022-2 · Cited by 149
The placental transfer of IgG subclasses in human pregnancy.
(1980) · PubMed Central · Cited by 142
Public health and the environment.
Wolman, A. (1985) · American Journal of Public Health · doi:10.2105/ajph.75.9.1049 · Cited by 124
Smits, G. P., van Gageldonk, P. G. M., Schouls, L. M., van der Klis, F. R. M., & Berbers, G. A. M. (2012) · Clinical and Vaccine Immunology · doi:10.1128/cvi.05537-11 · Cited by 122 · cited 1×
“Antibody concentrations in the serum samples were analyzed as previously described by Smits et al.[22] In short, serum samples were tested for antibodies against measles, mumps, rubella and varicella zoster virus (VZV) using a fluorescent bead-based multiplex immuno assay (MIA) (Luminex xMAP technology).”
MethodSelf-citationPlacental transfer and decay of maternally acquired antimeasles antibodies in Nigerian children
HARTTER, H. K., OYEDELE, O. I., DIETZ, K., KREIS, S., HOFFMAN, J. P., & MULLER, C. P. (2000) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200007000-00010 · Cited by 113 · cited 4×
“[14–17] Waaijenborg et al.”
Influentialvan den Berg, J. P., Westerbeek, E. A. M., Berbers, G. A. M., van Gageldonk, P. G. M., van der Klis, F. R. M., & van Elburg, R. M. (2010) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181dc4f77 · Cited by 112
Self-citationMeasles Epidemic in The Netherlands, 1999–2000
van den Hof, S., Spaendonck, M. A. E. C.-V., & van Steenbergen, J. (2002) · The Journal of Infectious Diseases · doi:10.1086/344894 · Cited by 108
Jauniaux, E., Jurkovic, D., Gulbis, B., Liesnard, C., Lees, C., & Campbell, S. (1995) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a135906 · Cited by 104
Early Loss of Passive Measles Antibody in Infants of Mothers With Vaccine-Induced Immunity
Maldonado, Y., Lawrence, E. C., DeHovitz, R., Hartzell, H., & Albrecht, P. (1995) · PEDIATRICS · doi:10.1542/peds.96.3.447 · Cited by 103 · cited 1×
“[40] In the coming years, almost all women of child bearing age will be vaccinated during childhood and therefore have lower antibody levels against measles, mumps and rubella.[41,42] In our study, 63% of the mothers of preterm infants were born before 1975 and therefore not vaccinated against mumps or measles, but we…”
BackgroundEuropean Centre for Disease Prevention and Control publishes Annual epidemiological report 2011.
(2011) · PubMed · Cited by 101
Reduced measles immunity in infants in a well-vaccinated population
PABST, H. F., SPADY, D. W., MARUSYK, R. G., CARSON, M. M., CHUI, L. W.-L., JOFFRES, M. R., & GRIMSRUD, K. M. (1992) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199207000-00004 · Cited by 91 · cited 1×
“[40] In the coming years, almost all women of child bearing age will be vaccinated during childhood and therefore have lower antibody levels against measles, mumps and rubella.[41,42] In our study, 63% of the mothers of preterm infants were born before 1975 and therefore not vaccinated against mumps or measles, but we…”
BackgroundOngoing mumps outbreak in a student population with high vaccination coverage, Netherlands, 2010
Whelan, J., van Binnendijk, R. S., Greenland, K., Fanoy, E. B., Khargi, M., Yap, K.-B., Boot, H. J., Veltman, N., Swaan, C. M., van der Bij, A., et al. (2010) · Eurosurveillance · doi:10.2807/ese.15.17.19554-en · Cited by 88
Greenland, K., Whelan, J., Fanoy, E. B., Borgert, M. J., Hulshof, K., Yap, K.-B., Swaan, C. M., Donker, T., van Binnendijk, R. S., de Melker, H. E., et al. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.04.083 · Cited by 80
Comparison of Vaccination with Measles-Mumps-Rubella Vaccine at 9, 12, and 15 Months of Age
Redd, S. C., King, G. E., Heath, J. L., Forghani, B., Bellini, W. J., & Markowitz, L. E. (2004) · The Journal of Infectious Diseases · doi:10.1086/378691 · Cited by 80 · cited 1×
“Low seroconversion is also caused by immaturity of the immune system[46,47] and maybe more important for an adequate response to MMR vaccinations in preterm infants administered at less than 12 months of age, compared to term infants.”
Backgroundvan den Hof, S., Berbers, G. A. M., de Melker, H. E., & Spaendonck, M. A. E. C.-V. (1999) · Vaccine · doi:10.1016/s0264-410x(99)00348-5 · Cited by 78
Self-citationLeineweber, B., Grote, V., Schaad, B., & Heininger, U. (2004) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200404000-00019 · Cited by 76
de Voer, R. M., van der Klis, F. R. M., Nooitgedagt, J. E., Versteegh, F. G. A., van Huisseling, J. C. M., van Rooijen, D. M., Sanders, E. A. M., & Berbers, G. A. M. (2009) · Clinical Infectious Diseases · doi:10.1086/599347 · Cited by 69
Self-citationEx vivo human placenta models: transport of immunoglobulin G and its subclasses
Malek, A. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00333-5 · Cited by 67 · cited 1×
“[7,8] While the fetal IgG is approximately 10% of the maternal concentration at 17–22 weeks of gestation, it increases to 50% at 28–32 weeks of gestation as determined by chordocentesis.[1,9] The increase of fetal IgG concentrations between 29 and 41 weeks of gestation is twice that at 17 to 28 weeks of gestation.”
BackgroundKlinge, J., Lugauer, S., Korn, K., Heininger, U., & STEHR, K. (2000) · Vaccine · doi:10.1016/s0264-410x(00)00096-7 · Cited by 61
Measles outbreak in Europe: Susceptibility of infants too young to be immunized
Leuridan, E. E., Sabbe, M., & Damme, P. V. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.07.035 · Cited by 58 · cited 4×
“[31,32] Increasing herd immunity by enhanced administration of MMR vaccination is therefore important for elimination of measles in Europe.”
BackgroundInfluentialMethods for screening the naturally acquired and vaccine-induced immunity to the mumps virus
CHRISTENSON, B., & Böttiger, M. (1990) · Biologicals · doi:10.1016/1045-1056(90)90009-o · Cited by 56
van der Zwet, W. C., Vandenbroucke-Grauls, C. M. J. E., van Elburg, R. M., Cranendonk, A., & Zaaijer, H. L. (2002) · Pediatrics · doi:10.1542/peds.109.1.79 · Cited by 50
Placental transfer of measles antibodies: effect of gestational age and maternal vaccination status
Linder, N., Tallen-Gozani, E., German, B., Duvdevani, P., Ferber, A., & Sirota, L. (2003) · Vaccine · doi:10.1016/j.vaccine.2003.10.009 · Cited by 48 · cited 4×
“Rubella (IU/ml) term 42 66 (42–102) [0–545] 39 48 (32–71) [0–291] 1.”
BackgroundInfluentialBorrás, E., Urbiztondo, L., Costa, J. M., Batalla, J., Torner, N., Plasència, A., Salleras, L., Domı́nguez, Á., & the Working Group for the Study of Measles Immunity in Children (2011) · Epidemiology and Infection · doi:10.1017/s0950268811002184 · Cited by 41 · cited 1×
“However, seroconversion is shown to be lower after early vaccination due to the presence of maternal antibodies and immaturity of the immune system.[44] Circulating maternal antibodies inhibit vaccine responses in infants by formation of immune complexes and epitope specific masking of B cell determinants.”
Background(2013) · PubMed · Cited by 39
Placental transfer and decay of varicella-zoster virus antibodies in preterm infants
Linder, N., Waintraub, I., Smetana, Z., Barzilai, A., Lubin, D., Mendelson, E., & Sirota, L. (2000) · The Journal of Pediatrics · doi:10.1067/mpd.2000.106902 · Cited by 38 · cited 4×
“Rubella (IU/ml) term 42 66 (42–102) [0–545] 39 48 (32–71) [0–291] 1.”
BackgroundInfluentialVaricella zoster virus infection occurs at a relatively young age in the Netherlands
van Lier, A., Smits, G. P., Mollema, L., Waaijenborg, S., Berbers, G. A. M., van der Klis, F. R. M., Boot, H. J., Wallinga, J., & de Melker, H. E. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.08.029 · Cited by 36
Self-citationHAAS, R. D., van den Hof, S., Berbers, G. A. M., de Melker, H. E., & Spaendonck, M. A. E. C.-V. (1999) · Epidemiology and Infection · doi:10.1017/s0950268899002939 · Cited by 35
Self-citationImmunity against measles in populations of women and infants in Poland
Janaszek, W., & Slusarczyk, J. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00113-0 · Cited by 32 · cited 1×
“Vaccination induces lower antibody levels compared to natural infection,[38,39] and due to high vaccine coverage, antibody levels will in general not be boosted by exposure to the wild-type virus.”
BackgroundWesterbeek, E. A. M., van Elburg, R. M., van den Berg, A., van den Berg, J., Twisk, J. W. R., Fetter, W. P. F., & Lafeber, H. N. (2008) · BMC Pediatrics · doi:10.1186/1471-2431-8-46 · Cited by 32 · cited 2×
“Ethics statement This study was part of the CARROT study, registered as ISRCTN16211826 [21] and conducted according to the guidelines laid down in the Declaration of Helsinki and the medical ethical review board of VU University Medical Center approved all procedures involving human patients.”
MethodSelf-citationEARLY LOSS OF PASSIVE MEASLES ANTIBODY IN INFANTS OF MOTHERS WITH VACCINE-INDUCED IMMUNITY
Kobayashi, R. H., & Kobayashi, A. D. (1996) · PEDIATRICS · doi:10.1542/peds.98.2.353a · Cited by 30
Evidence and policymaking: The introduction of MMR vaccine in the Netherlands
Blume, S. S., & Tump, J. (2010) · Social Science & Medicine · doi:10.1016/j.socscimed.2010.06.023 · Cited by 30 · cited 1×
“The MMR-combination vaccine was implemented in 1987 with a catch-up campaign.[13] Any antibodies against mumps or measles in mothers born before 1975 and antibodies against rubella in mothers born before 1963, must therefore be naturally acquired.”
MethodZanetta, R. A. C., Amaku, M., Azevedo, R. S., Zanetta, D. M. T., Burattini, M. N., & Massad, E. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00267-5 · Cited by 30 · cited 4×
“[14–17] Waaijenborg et al.”
InfluentialMeasles antibodies in women and infants in the vaccine era.
Kacica, M. A., Hughes, P. A., LEPOW, M. L., Venzia, R. A., & Miller, J. D. (1995) · Journal of Medical Virology · doi:10.1002/jmv.1890450220 · Cited by 29 · cited 1×
“Vaccination induces lower antibody levels compared to natural infection,[38,39] and due to high vaccine coverage, antibody levels will in general not be boosted by exposure to the wild-type virus.”
BackgroundMeasles Outbreak, the Netherlands, 2008
Hahné, S., Wierik, M. J. M. T., Mollema, L., van Velzen, E., de Coster, E., Swaan, C. M., de Melker, H. E., & van Binnendijk, R. (2010) · Emerging infectious diseases · doi:10.3201/eid1602.090114 · Cited by 27
Measles Outbreak, the Netherlands, 2008
Hahné, S. J. M. (2010) · Emerging infectious diseases · doi:10.3201/eid1603.090114 · Cited by 19
Methods for screening the naturally acquired and vaccine-induced immunity to the measles virus
CHRISTENSON, B., & Böttiger, M. (1990) · Biologicals · doi:10.1016/1045-1056(90)90008-n · Cited by 19 · cited 6×
“Protective concentrations for antimumps and anti-varicella antibodies are not internationally assigned, but locally assigned cut-off values of $45 RU/ml and $0.26 IU/ml, respectively, were used as previously described.”
InfluentialOhsaki, M. (1999) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365549950161826 · Cited by 14 · cited 1×
“Vaccination induces lower antibody levels compared to natural infection,[38,39] and due to high vaccine coverage, antibody levels will in general not be boosted by exposure to the wild-type virus.[40] In the coming years, almost all women of child bearing age will be vaccinated during childhood and therefore have lowe…”
BackgroundMeasles Outbreak Among Members of a Religious Community — Brooklyn, New York, March–June 2013
Arciuolo, R. J., Brantley, T., Asfaw, M., Jablonski, R. R., Fu, J., Giancotti, F. R., Rosen, J. B., & Zucker, J. R. (2013) · PubMed Central · Cited by 10
Vaccination guidelines for female infertility patients
(2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.08.056 · Cited by 9
Effect of early measles vaccination ( AIK ‐ C strain) for preterm infants
Ichikawa, T., Tsuji, A., Fujino, M., Kusano, R., Sugiyama, R., Oomori, S., Mori, K. J., Maeyama, K., & Nakayama, T. (2013) · Pediatrics International · doi:10.1111/ped.12064 · Cited by 7 · cited 1×
“[49] Evidence for MMR vaccination at 6 months in preterm infants is scarce, but Ichikawa et al showed that early immunization at 6 months of age was protective against measles in 17 preterm infants.[50] If there is no direct risk of contact with the viruses, longer protection by maternal antibodies in combination with…”
BackgroundComparison of Fingerstick Versus Venipuncture for Antibody Testing of Measles and Rubella
Pinsky, N. A., Loepfe, T. R., Jacobson, R. M., Vierkant, R. A., & Poland, G. A. (2003) · Scandinavian Journal of Infectious Diseases · doi:10.1080/0036554021000027008 · Cited by 5 · cited 1×
“However, this difference did not influence the results of the study.[53] Second, the follow-up blood sampling was chosen at 5 months because this was 4–6 weeks after the primary series of DTaP-IPV-Hib vaccinations.”
Research works printed but not linked: 2
- J Klinge, 2000, Comparison of immunogenicity and reactogenicity of a measles, mumps and rubella (MMR) vaccine in German children vaccinated at 9–11, 12–14 or 15–17 months of age, Vaccine, 18, 3134
- PFA McLean HQ, 2013, Prevention of Measles, Rubella, Congenital Rubella Syndrome, and Mumps, 2013: Summary Recommendations of the Advisory Committee on Immunization Practices (ACIP), MMWR Recomm Rep, 62, 1
Cited by
Wilcox, C. R., Holder, B., & Jones, C. E. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01294 · Cited by 200
“It follows therefore that a reduced transfer of IgG in pre-term infants compared with term infants has been demonstrated for a variety of pathogens (127) (97) (128) particularly for infants born at less than 36 weeks of gestation (126).”
BackgroundVertically Transferred Immunity in Neonates: Mothers, Mechanisms and Mediators
Albrecht, M., & Arck, P. C. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00555 · Cited by 199
“infants Prospective observational study 138 (59)”
Maternal immunisation: collaborating with mother nature
Marchant, A., Sadarangani, M., Garand, M., Dauby, N., Verhasselt, V., Pereira, L., Bjornson, G., Jones, C. E., Halperin, S. A., Edwards, K. M., et al. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30229-3 · Cited by 183
Vedolizumab exposure in pregnancy: outcomes from clinical studies in inflammatory bowel disease
Mahadevan, U., Vermeire, S., Lasch, K. L., Abhyankar, B., Bhayat, F., Blake, A., & Dubinsky, M. C. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13960 · Cited by 132
“As a result, it has been demonstrated that there are significantly lower levels of seroprotection to vaccine-preventable diseases, such as measles, mumps and rubella, in pre-term compared with full-term infants.(36) At term, foetal IgG levels typically”
BackgroundImmunomodulation to Prevent or Treat Neonatal Sepsis: Past, Present, and Future
Schüller, S. S., Kramer, B. W. W., Villamor, E., Spittler, A., Berger, A., & Levy, O. (2018) · Frontiers in Pediatrics · doi:10.3389/fped.2018.00199 · Cited by 78
Metadata
- Authors
- van den Berg, J. P., Westerbeek, E. A. M., Smits, G. P., van der Klis, F. R. M., Berbers, G. A. M., & van Elburg, R. M.
- Affiliations
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
- National Institute for Public Health and the Environment (NL)
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-04-11
- Volume
- 9
- Issue
- 4
- Pages
- e94714
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3984210
- OpenAlex
- W2003449245
- Cited by
- 54
- References
- 53
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 5 · 2023: 6 · 2022: 7 · 2021: 3 · 2020: 2 · 2019: 5 · 2018: 6 · 2017: 7 · 2016: 2 · 2015: 4
- FWCI
- 3.27
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Rivm Repository (Netherlands National Institute for Public Health and the Environment) (submittedVersion)
- Funders
- Danone
- Vrije Universiteit Amsterdam
- Topics
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Neonatal and Maternal Infections
- Keywords
- transplacental antibody transfer, preterm infants, very preterm infants, measles, mumps, rubella, varicella zoster, maternal antibodies, umbilical cord blood, term infants, neonatal immunity
- MeSH terms
- Adult, Antibodies, Viral, Chickenpox, Female, Humans, Immunoglobulin G, Immunity, Maternally-Acquired, Infant, Newborn, Infant, Premature, Measles, Mumps, Placenta, Pregnancy, Rubella virus, Seroepidemiologic Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

